WSLHD
Skip navigation
Please use this identifier to cite or link to this item: https://wslhd.intersearch.com.au/wslhdjspui/handle/1/7026
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLippi, G.-
dc.contributor.authorHenry, B. M.-
dc.contributor.authorFavaloro, Emmanuel J.-
dc.date.accessioned2023-06-05T06:13:26Z-
dc.date.available2023-06-05T06:13:26Z-
dc.date.issued2023-
dc.identifier.citationSeminars in Thrombosis & Hemostasis 49(1):73-75, 2023-
dc.identifier.urihttps://wslhd.intersearch.com.au/wslhdjspui/handle/1/7026-
dc.titleThe Benefits of Heparin Use in COVID-19: Pleiotropic Antiviral Activity beyond Anticoagulant and Anti-Inflammatory Properties-
dc.typeJournal Article-
dc.identifier.doihttps://dx.doi.org/10.1055/s-0042-1742740-
dc.subject.keywordsAnticoagulants-
dc.subject.keywordscovid-19-
dc.subject.keywordsAntiviral Agents-
dc.subject.keywordsHeparin-
dc.subject.keywordsAnti-Inflammatory Agents-
dc.identifier.journaltitleSeminars in Thrombosis & Hemostasis-
dc.identifier.pmid35158389-
dc.contributor.wslhdFavaloro, Emmanuel J.-
dc.identifier.facilityWestmead-
Appears in Collections:Westmead Hospital 2019 - 2024

Files in This Item:
There are no files associated with this item.


Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.